growth

Investing.com — Shares of Blueprint Medicines (NASDAQ:) Corporation (NASDAQ:BPMC) climbed 17% as the company outlined its growth strategy for 2025, highlighting the potential of its systemic mastocytosis (SM) franchise and positive trial data for its new treatment, BLU-808. Blueprint Medicines, based in Cambridge, Massachusetts, updated its peak revenue estimate for…

By Caroline Valetkevitch NEW YORK (Reuters) – Investors are watching to see if technology companies and related heavyweights will add to recent strong profit gains and whether growth is broadening to other sectors as corporate America prepares to report on the final quarter of another standout year for Wall Street.…

Investing.com — Marks & Spencer (LON:) has reported strong results during the Christmas trading period, signaling continued momentum in its revival efforts.  The retailer posted an 8.7% increase in food sales, with like-for-like sales rising by 8.9%.  Sustained UK volume growth of 6.6% from the first half of the financial…